Dingdang Health Maintains Share Count, Adds to Buybacks; Cumulative Repurchases Reach 43.57 Million Shares

Bulletin Express04-22

Dingdang Health Technology Group Ltd. disclosed that its issued ordinary share capital remained unchanged at 1.32 billion shares as of 22 April 2026, with no new shares issued or cancelled during the reporting day.

The company continued its share repurchase programme: • On 22 April 2026, Dingdang Health bought back 601,500 shares on the Hong Kong Stock Exchange at prices between HKD 1.08 and HKD 1.13, spending HKD 0.66 million. • All repurchased shares are designated for cancellation; none are being held as treasury stock.

Progress under the current mandate authorised on 28 May 2025: • Total mandate: 131.95 million shares. • Cumulative repurchases to date: 43.57 million shares, equivalent to 3.30 % of the company’s issued share capital on the mandate date. • Remaining capacity: 88.38 million shares.

Following the latest buyback, Dingdang Health is subject to a moratorium on new share issues or treasury-share sales until 22 May 2026, in accordance with Hong Kong Stock Exchange rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1153080127?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-22 18:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153080127","market":"hk","top_or_hot":-1,"title":"Dingdang Health Maintains Share Count, Adds to Buybacks; Cumulative Repurchases Reach 43.57 Million Shares","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. disclosed that its issued ordinary share capital remained unchanged at 1.32 billion shares as of 22 April 2026, with no new shares issued or cancelled during the reporting day.</p>\n<p>The company continued its share repurchase programme:\n• On 22 April 2026, Dingdang Health bought back 601,500 shares on the Hong Kong Stock Exchange at prices between HKD 1.08 and HKD 1.13, spending HKD 0.66 million.  \n• All repurchased shares are designated for cancellation; none are being held as treasury stock.</p>\n<p>Progress under the current mandate authorised on 28 May 2025:\n• Total mandate: 131.95 million shares.  \n• Cumulative repurchases to date: 43.57 million shares, equivalent to 3.30 % of the company’s issued share capital on the mandate date.  \n• Remaining capacity: 88.38 million shares.</p>\n<p>Following the latest buyback, Dingdang Health is subject to a moratorium on new share issues or treasury-share sales until 22 May 2026, in accordance with Hong Kong Stock Exchange rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health Maintains Share Count, Adds to Buybacks; Cumulative Repurchases Reach 43.57 Million Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health Maintains Share Count, Adds to Buybacks; Cumulative Repurchases Reach 43.57 Million Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-22 18:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. disclosed that its issued ordinary share capital remained unchanged at 1.32 billion shares as of 22 April 2026, with no new shares issued or cancelled during the reporting day.</p>\n<p>The company continued its share repurchase programme:\n• On 22 April 2026, Dingdang Health bought back 601,500 shares on the Hong Kong Stock Exchange at prices between HKD 1.08 and HKD 1.13, spending HKD 0.66 million.  \n• All repurchased shares are designated for cancellation; none are being held as treasury stock.</p>\n<p>Progress under the current mandate authorised on 28 May 2025:\n• Total mandate: 131.95 million shares.  \n• Cumulative repurchases to date: 43.57 million shares, equivalent to 3.30 % of the company’s issued share capital on the mandate date.  \n• Remaining capacity: 88.38 million shares.</p>\n<p>Following the latest buyback, Dingdang Health is subject to a moratorium on new share issues or treasury-share sales until 22 May 2026, in accordance with Hong Kong Stock Exchange rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1153080127","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153080127","pubTimestamp":1776854779,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. disclosed that its issued ordinary share capital remained unchanged at 1.32 billion shares as of 22 April 2026, with no new shares issued or cancelled during the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康维持股份数量，加大回购力度；累计回购达4357万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. disclosed that its issued ordinary share capital remained unchanged at 1.32 billion shares as of 22 April 2026, with no new shares issued or cancelled during the reporting day.\nThe company continued its share repurchase programme:\n• On 22 April 2026, Dingdang Health bought back 601,500 shares on the Hong Kong Stock Exchange at prices between HKD 1.08 and HKD 1.13, spending HKD 0.66 million.  \n• All repurchased shares are designated for cancellation; none are being held as treasury stock.\nProgress under the current mandate authorised on 28 May 2025:\n• Total mandate: 131.95 million shares.  \n• Cumulative repurchases to date: 43.57 million shares, equivalent to 3.30 % of the company’s issued share capital on the mandate date.  \n• Remaining capacity: 88.38 million shares.\nFollowing the latest buyback, Dingdang Health is subject to a moratorium on new share issues or treasury-share sales until 22 May 2026, in accordance with Hong Kong Stock Exchange rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1153080127","isCrawlerRequest":true}